Covered recipient · General Payments record
SABA N AHMED
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2023–2024
$279.23
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $234.90 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $111.66 | 4 |
| Novo Nordisk AS | $80.01 | 4 |
| Acerta Pharma LLC | $43.23 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.21 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103186340 | CMS |
| ABBVIE INC. | $27.91 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103186342 | CMS |
| ABBVIE INC. | $28.68 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103186344 | CMS |
| ABBVIE INC. | $20.86 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103186346 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.90 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105755249 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.26 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104411063 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.07 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105632389 | CMS |
| Novo Nordisk Inc | $15.64 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096971517 | CMS |
| Novo Nordisk Inc | $13.91 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097491518 | CMS |
| Novo Nordisk Inc | $26.26 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097671937 | CMS |
| Novo Nordisk Inc | $24.20 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097813700 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.